Tag: FDA

Investigation of Filter Integrity Failures during Campaign Changeovers in Pharmaceutical Manufacturing Filter integrity failures during campaign changeovers can disrupt production lines, compromise product quality, and initiate regulatory scrutiny. Such incidents…

Investigating Endotoxin OOS in Campaign Changeovers: Ensuring Data Integrity on the Lab and Shop Floor In the pharmaceutical manufacturing sector, one of the critical challenges encountered during campaign changeovers is…

Sterility Test Failure During Terminal Sterilization: Classifying Deviation and Setting Disposition In the highly regulated environment of pharmaceutical manufacturing, sterility test failures during terminal sterilization processes present a significant challenge.…

How to Address Media Fill Failures during PAI Readiness: A Structured Approach to Deviation Classification and Disposition In the pharmaceutical industry, media fill failures can pose significant challenges during process…

Understanding Media Fill Failures in Routine Environmental Monitoring: A Comprehensive FDA/MHRA Investigation Guide Media fill failures during routine environmental monitoring (EM) can pose significant challenges to pharmaceutical manufacturers, especially in…

Investigation of Filter Integrity Failures during Hold-Time Studies in Pharmaceutical Manufacturing During routine quality control activities, a filter integrity failure was recorded during a hold-time study for parenteral dosage forms.…

Assessing Smoke Study Failures in Aseptic Filling: A Comprehensive Investigation Framework In the highly regulated world of pharmaceutical manufacturing, maintaining aseptic conditions during drug production is crucial for ensuring patient…

Exploring Em Excursion in Grade A During Hold-Time Studies: A Comprehensive Investigation Approach In pharmaceutical manufacturing, maintaining product integrity and quality is paramount. One significant area of concern arises when…